TREAT HYPOTENSION AND/OR ELEVATED LACTATE WITH FLUIDS
Corresponding Bundle Element
In the event of hypotension and/or lactate > 4 mmol/L (36 mg/dL) deliver an initial minimum of 20 mL/kg of crystalloid (or colloid equivalent).
Background
Patients with severe sepsis and septic shock may experience ineffective arterial circulation due to the vasodilatation associated with infection or impaired cardiac output. Poorly perfused tissue beds result in global tissue hypoxia, which is often found in association with an elevated serum lactate level. A serum lactate value greater than 4 mmol/L (36 mg/dl) is correlated with increased severity of illness and poorer outcomes even if hypotension is not yet present. As such, patients who are hypotensive or have a lactate greater than 4 mmol/L (36 g/dL) require intravenous fluids or colloid to expand their circulating volume and effectively restore perfusion pressure.
Initial Fluid Administration
The Severe Sepsis Resuscitation Bundle calls for an initial administration of 20 mL/kg of crystalloid as a fluid challenge in cases of suspected hypovolemia or actual cases of serum lactate greater than 4 mmol/L (36 g/dL). A colloid equivalent is an acceptable alternative to crystalloid, and an equivalent dose generally ranges from 0.2 g/kg to 0.3 g/kg depending upon the colloid.
Fluid resuscitation should be commenced as early as possible in the course of septic shock (even before intensive care unit admission). Requirements for fluid infusion are not easily determined so that repeated fluid challenges should be performed.
The bundle does not restrict the amount and extent of an initial fluid challenge, but rather defines a minimum challenge. Subsequent actions in the bundle are undertaken only for hypotension not responding to fluid challenge or for an elevated lactate level as above.
Fluid Challenge vs. Increase in Maintenance Fluid
An increase in maintenance fluid administration must be distinguished from fluid challenge. Fluid challenge is a term used to describe the initial volume expansion period in which the response of the patient to fluid administration is carefully evaluated. During this process, large amounts of fluids may be administered over a short period of time under close monitoring to evaluate the patient’s response.
Fluid challenges require the definition of four components: 1) the type of fluid to be administered (e.g., natural or artificial colloids, crystalloids); 2) the rate of fluid infusion (e.g., 500–1000 mL over 30 mins); 3) the end points (e.g., mean arterial pressure of >70 mm Hg, heart rate of <110 beats/min); and 4) the safety limits (e.g., development of pulmonary edema). Maintenance fluid increases typically alter only the rate of administration of continuous fluids.
Crystalloid vs. Colloid
Although prospective studies of choice of fluid resuscitation in patients with septic shock only are lacking, a prospective, controlled, randomized, double-blind study comparing 4 percent human albumin solution with 0.9 percent sodium chloride (saline) in critically ill patients requiring fluid resuscitation (the Saline vs. Albumin Fluid Evaluation (SAFE) study) has recently been completed, having enrolled 7,000 patients. The results of this study showed identical mortality rate in patients receiving albumin or 0.9 percent sodium chloride. Subgroup analysis revealed that albumin might have some (albeit not statistically significant) benefit in patients with severe sepsis. [1]
In addition, meta-analyses of clinical studies comparing crystalloid and colloid resuscitation in general and surgical patient populations indicate no clinical outcome difference between colloids and crystalloids and would appear to be generalizable to sepsis populations. [2-4] As the volume of distribution is much larger for crystalloids than for colloids, resuscitation with crystalloids requires more fluid to achieve the same goals and results in more edema.
End Points of Fluid Resuscitation
As regards the Sepsis Resuscitation Bundle, a minimum fluid challenge is defined in an effort to avoid hypotension. The bundle does not restrict additional fluids. If, however, the patient should enter the early goal-directed phases of the Resuscitation Bundle either for hypotension not responding to fluid challenges or an lactate greater than 4 mmol/L (36 g/dl), targets for central venous pressure as well as central and mixed venous oxygen saturation have been defined. These targets are not arbitrary. They are based upon specifications defined in the best available literature, Rivers et al. [5] and a recent analysis supporting a 65 percent SvO2 saturation as similar to a 70 percent ScvO2. [6]
In Rivers et al., hospital mortality was 30.5 percent in the group assigned to early goal-directed therapy, compared with 46.5 percent in the standard therapy group (p = .009). Rivers et al. used restoration of a central venous oxygen saturation of >70 percent as one of their goals, and this was met in 95 percent of the early goal-directed group, compared with just 60 percent of the standard treatment group (p < .001). Patients in the early goal-directed treatment groups received more fluids (5 vs. 3.5 L, p< .001) and more were given red cell transfusions (64 vs. 18.5 percent, p< .001) in the first 6 hours than in the standard treatment group, emphasizing the importance of early and adequate fluid resuscitation in patients with severe sepsis.
However, considerable debate remains on these thresholds largely because of problems in monitoring the regional microcirculation and oxygenation. Changes may persist at a local level while systemic hemodynamic and oxygenation variables seem to have stabilized. Each end point must be considered in its context, and the combination of clinical variables (mean arterial pressure, urine output, apparent skin perfusion, level of consciousness) along with serum lactate values may be helpful to the clinician despite a lack of randomized trials to establish this point.
Safety Margins
Patients should be carefully observed for evidence of pulmonary and systemic edema during fluid resuscitation. The degree of intravascular volume deficit in patients with severe sepsis varies. With venodilation and ongoing capillary leak, most patients require continuing aggressive fluid resuscitation during the first 24 hours of management. Input is typically much greater than output, and input/output ratio is of no utility to judge fluid resuscitation needs during this time.
Grading the Evidence
1. The Surviving Sepsis Campaign recommends fluid resuscitation with either natural/artificial colloids or crystalloids. There is no evidence-based support for one type of fluid over another (Grade 1B).
Rationale. The SAFE study indicated albumin administration was safe and equally effective as crystalloid [1]. There was an insignificant decrease in mortality rates with the use of colloid in a subset analysis of septic patients (p= 0.09). Previous meta-analyses of small studies of ICU patients had demonstrated no difference between crystalloid and colloid fluid resuscitation [2-4]. Although administration of hydroxyethyl starch may increase the risk of acute renal failure in patients with sepsis, variable findings preclude definitive recommendations [7,8]. As the volume of distribution is much larger for crystalloids than for colloids, resuscitation with crystalloids requires more fluid to achieve the same end points and results in more edema. Crystalloids are less expensive.
2. The Surviving Sepsis Campaign recommends fluid resuscitation initially target a CVP of at least 8 mm Hg (12 mm Hg in mechanically ventilated patients). Further fluid therapy is often required (Grade 1C).
3a. The Surviving Sepsis Campaign recommends that a fluid challenge technique be applied, wherein fluid administration is continued as long as the hemodynamic improvement (e.g., arterial pressure, heart rate, urine output) continues. (Grade 1D)
3b. The Surviving Sepsis Campaign recommends fluid challenge in patients with suspected hypovolemia be started with at least 1000 mL of crystalloids or 300-500 mL of colloids over 30 min. More rapid administration and greater amounts of fluid may be needed in patients with sepsis-induced tissue hypoperfusion (Grade 1D)
3c. The Surviving Sepsis Campaign recommends the rate of fluid administration be reduced substantially when cardiac filling pressures (CVP or pulmonary artery balloon-occluded pressure) increase without concurrent hemodynamic improvement (Grade 1D).
Rationale. Fluid challenge must be clearly separated from simple fluid administration; it is a technique in which large amounts of fluids are administered over a limited period of time under close monitoring to evaluate the patient’s response and avoid the development of pulmonary edema. The degree of intravascular volume deficit in patients with severe sepsis varies. With venodilation and ongoing capillary leak, most patients require continuing aggressive fluid resuscitation during the first 24 hours of management. Input is typically much greater than output, and input/output ratio is of no utility to judge fluid resuscitation needs during this time period.
The above category 1 recommendations are strong recommendations for care based on a number of qualitative considerations. “B” level evidence generally derives from randomized control trials with certain limitations or very well-done observational or cohort studies. “C” level evidence reflects well-done observational or cohort studies with controls. “D” level evidence generally reflects case series data or expert opinion.
Tips
1. Establish a standardized protocol for managing septic patients with shock that includes immediate fluid resuscitation as above. Detail the type, amount, and duration of the initial bolus. Detail the same for subsequent fluid challenges.
2. Do not delay the beginning of fluid administration for placement of central access.
3. Be prepared to deliver additional fluids. In order to reach the target central venous pressure (CVP) goal of >8 mm Hg in subsequent steps, volumes much greater than the initial 20 mL/kg or colloid equivalent may be required.
4. If the patient is not responding to vigorous volume resuscitation, think of other causes of hypotension such as depressed myocardial function, adrenal insufficiency, tension pneumothorax, cardiac tamponade, etc.
5. If using crystalloid, be sure to use isotonic fluids such as normal saline or lactated Ringer’s only.
References
1. Finfer S, Bellomo R, Boyce N, et al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med. 2004;350:2247–2256.
2. Choi PTL, Yip G, Quinonez LG, et al. Crystalloids vs. colloids in fluid resuscitation: a systematic review. Crit Care Med. 1999;27:200–210.
3. Cook D, Guyatt G. Colloid use for fluid resuscitation: evidence and spin. Ann Intern Med. 2001;135:205–208.
4. Schierhout G, Roberts I. Fluid resuscitation with colloid or crystalloid solutions in critically ill patients: a systematic review of randomized trials. BMJ. 1998;316:961–964.
5. Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345:1368–1377.
6. Reinhart K, Kuhn HJ, Hartog C, et al. Continuous central venous and pulmonary artery oxygen saturation monitoring in the critically ill. Intensive Care Med. 2004;30:1572–1578.
7. Schortgen F, Lacherade JC, Bruneel F, et al. Effects of hydroxyethyl starch and gelatin on renal function in severe sepsis: a multicentre randomised study. Lancet 2001; 357:911-916
8. Sakr Y, Payen D, Reinhart K, et al. Effects of hydroxyethyl starch administration on renal function in critically ill patients. Br J Anaesth. 2007;98:216-224.
Content adapted extensively from:
• Dellinger, RP, Levy, MM, Carlet, JM, et al. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008; [published correction appears in Crit Care Med 2008; 36:1394-1396] 36:296-327
• Vincent JL, Gerlach H. Fluid resuscitation in severe sepsis and septic shock: An evidence based review. Crit Care Med. 2004;32(Suppl.):S451-S43.
• Rhodes A, Bennett ED. Early goal-directed therapy: an evidence-based review. Crit Care Med. 2004;32(Suppl.):S448–S450.